(19)
(11) EP 2 046 313 A1

(12)

(43) Date of publication:
15.04.2009 Bulletin 2009/16

(21) Application number: 07769053.5

(22) Date of filing: 06.07.2007
(51) International Patent Classification (IPC): 
A61K 31/122(2006.01)
A61P 3/10(2006.01)
 A61K 31/37(2006.01)
(86) International application number:
PCT/SE2007/050507
(87) International publication number:
WO 2008/008033 (17.01.2008 Gazette 2008/03)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 10.07.2006 SE 0601503
04.12.2006 SE 0602611

(71) Applicant: Glucox Biotech AB
118 50 Stockholm (SE)

(72) Inventors:
  • WILCKE, Mona
    118 50 Stockholm (SE)
  • SVENSSON, Bo
    118 50 Stockholm (SE)
  • WALSE, Björn
    118 50 Stockholm (SE)
  • BENGTSSON, Tore
    118 50 Stockholm (SE)

(74) Representative: Rystedt, Per Hampus et al
BRANN AB Uppsala Office P.O. Box 17 192
104 62 Stockholm
104 62 Stockholm (SE)

   


(54) THE USE OF NAPHTOQUINONES IN THE TREATMENT AND CONTROL OF DIABETES, INSULIN RESISTANCE AND HYPERGLYCEMIA